SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-014712
Filing Date
2017-08-14
Accepted
2017-08-14 16:16:24
Documents
65
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20170630_10q.htm 10-Q 855735
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10956
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 11028
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6192
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6128
12 dffn20170630_10qimg002.jpg GRAPHIC 27368
  Complete submission text file 0001437749-17-014712.txt   4897633

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS dffn-20170630.xml EX-101.INS 992931
7 EXHIBIT 101.SCH dffn-20170630.xsd EX-101.SCH 54059
8 EXHIBIT 101.CAL dffn-20170630_cal.xml EX-101.CAL 28642
9 EXHIBIT 101.DEF dffn-20170630_def.xml EX-101.DEF 359358
10 EXHIBIT 101.LAB dffn-20170630_lab.xml EX-101.LAB 313421
11 EXHIBIT 101.PRE dffn-20170630_pre.xml EX-101.PRE 379486
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 171030328
SIC: 2834 Pharmaceutical Preparations